Clinical Trial Update: Immunological Biomarkers in Tuberculosis Management [NA]

View source ↗

Summary

A clinical trial in Lyon is evaluating immunological biomarkers to improve tuberculosis management and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Tuberculosis, Tuberculosis Infection | NA | Status: RECRUITING